Global private equity firm KKR has acquired Medicover's Indian hospital operations for approximately $1.3 billion, representing the largest single investment cheque the American firm has written for a transaction in India to date.

The deal marks KKR's continued expansion into India's healthcare sector and represents Medicover's complete exit from the Indian market. Medicover, a Sweden-based healthcare and diagnostic services provider, will redirect its strategic focus entirely toward its European operations following the divestiture.

The $1.3 billion transaction underscores growing interest from major global investment firms in India's healthcare industry, which has attracted significant capital amid rising demand for quality medical services across the country. India's hospital sector has become a focus area for private equity and sovereign wealth funds, with firms such as Blackstone, TPG, Bain Capital, and Temasek also deploying capital into healthcare chains in recent years. Demand is being driven by a growing middle class, rising prevalence of chronic and lifestyle diseases, expanding health insurance coverage, and medical tourism.

KKR, founded in 1976 and headquartered in New York, is one of the world's largest alternative investment firms, managing hundreds of billions of dollars in assets across private equity, credit, and real estate. The firm has been an active investor in India across multiple sectors over the past two decades. Its prior healthcare-related investments in the country have included hospital and pharmaceutical assets, making healthcare an increasingly important component of its India strategy.

The acquisition adds to KKR's broader healthcare portfolio and signals continued confidence in the long-term growth prospects of India's private hospital market, where consolidation has been accelerating as large chains acquire smaller regional players to expand into tier-2 and tier-3 cities.

Source: CNBC-TV18